This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC 2022 Programme

Subpage Hero



Management & Treatment of VTE Patients – Practical advice for Pharmacists

14 May 2022







This session has been fully organised and funded by Bayer and contains promotional content. Adverse event reporting and prescribing information is available at the end of the presentation. 

This presentation will provide an overview from a pharmacist’s perspective of the practicalities of managing patients with venous thromboembolism (VTE), in line with current national guidelines. With a focus on anticoagulation in VTE, the clinical evidence for the use of DOACs for the management of acute VTE and prevention of VTE recurrence will be examined along with the considerations surrounding extended anticoagulation in at-risk patients and the management of cancer-associated thrombosis (CAT).

RP-XAR-GB-4123, March 2022


Anthony Hackett, Senior VTE Lead Pharmacist - St Thomas’ Hospital, London


Lead Education Partner

  • CPPE
  • Morph


Education Partner

  • BOPA
  • BPNG
  • CMHP
  • Health Education England


Education Partner

  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC


Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS


Education Partner

  • Soar Beyond
  • NHCA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS


Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber


Nominated Charity

  • Pharmacist Support


Newsletter Sign Up